Testing a single high-dose radiation treatment for solid tumor metastases
Part of Cancer clinical trials.
This trial tests powerful, precisely aimed radiation (MR-guided stereotactic body radiation therapy) in a single session to treat 1 to 3 small metastatic tumors outside the brain and spine. It aims to control cancer growth with fewer visits and less impact on healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a solid tumor that has spread to 1 to 3 other spots in the body (not in the brain or spine).
- Each tumor must be 5 centimeters or smaller and located somewhere that can be treated safely with one session of focused radiation.
- You have not had radiation in the same area before.
- Your blood counts (neutrophils, hemoglobin, platelets) and liver function (bilirubin, AST, ALT) are within safe ranges.
- You cannot be pregnant or breastfeeding, and you need to be able to have an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precise type of radiation that targets multiple tumor spots in a carefully planned way. It may help people with many metastatic (spread) solid tumors when standard treatments aren’t working or can’t be used.
This trial compares two stereotactic radiation strategies for patients who have intact (not previously radiated) brain metastases that are limited in size. It aims to see which approach works best in controlling the cancer while reducing side effects.
This trial tests a local treatment approach (focused radiation) for people with multiple brain metastases. It may help by targeting several spots in the brain while keeping treatment within certain size and safety limits.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
This study tests whether a focused, high-precision type of radiation can control many cancer spread-out spots (“metastases”) at the same time, while keeping side effects acceptable. It may help people with many metastases live longer or have better disease control by aiming treatment at every treatable spot.
This Phase 2 study tests whether adding a very focused type of radiation to standard drug treatment can better control metastatic breast cancer. It is for people whose cancer is only progressing in one spot, seen on a PET scan.
Hear when a new Metastatic Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.